QualityStocksNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Reduces Debt, Restructures Balance Sheet
Endonovo Therapeutics (OTCQB: ENDV) today announced the reduction of current liabilities and restructuring of the balance sheet through the approved modification of the terms of the Preferred C shares. “Strengthening our balance sheet is a priority we feel is instrumental in our continued and long-term success. This reduction of debt provides us the flexibility to expand our sales and marketing initiatives and to further develop our nationwide reach to hospitals and other medical facilities we have identified as prospective partners without having financial restraints,” Endonovo Therapeutics CEO Alan Collier said in the news release. “Additionally, reducing the debt increases our…